Some patients starting GLP-1 therapy experience sleep changes, appetite shifts, or stress related to behavioral adjustments, all of which can influence immune homeostasis
Gastrointestinal side effects are typically most pronounced during the initial weeks of treatment and following dose increases
Results Clinically observable results after regular use of the mask (2 to 3 times per week for 4 weeks), based on the pharmacodynamic mechanisms of its active ingredients: Week 1: Improvement in transepidermal hydration (TEWL up to 20%) thanks to hyaluronic acid and ceramide NP
The transport system consists of three main proteins, the first of which is the enzyme carnitine palmitoyltransferase I (CPTI) present in the mitochondrial outer membrane that complexes with a long-chain acyl-CoA synthetase and the voltage-dependent anion channel, while the second transport component is carnitine:acylcarnitine translocase (CACT), an integral inner membrane protein, which complexes with carnitine palmitoyltransferase II (CPTII) located on the matrix side of the inner membrane
Whether the increase of Lactobacillus in GD plays a protective or pathogenic role in the pathogenesis of depression remains to be further studied
